Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada The Challenge of cmc Regulatory Compliance for Biopharmaceuticals
Type
Physical Book
Publisher
Author
Year
2003
Language
English
Pages
350
Format
Hardcover
Weight
2
ISBN
0306480409
ISBN13
9780306480409
Edition No.
2004
Categories

The Challenge of cmc Regulatory Compliance for Biopharmaceuticals

John Geigert (Author) · Springer · Hardcover

The Challenge of cmc Regulatory Compliance for Biopharmaceuticals - John Geigert

Cheaper New Book Imported to New Zealand
Delivery: 17 Jul - 29 Jul Shipping: 12 to 16 business days.
NZ$ 394.88
Faster New Book Imported to New Zealand
Delivery: 07 Jul - 14 Jul Shipping: 4 to 5 business days.
NZ$ 551.37
Import costs and 15% GST included in the price ✅
NZ$ 394.88

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "The Challenge of cmc Regulatory Compliance for Biopharmaceuticals "

"The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that would rapidly become out of date. My primary purpose was to provide insight and practical suggestions into a common sense business approach to manage the CMC regulatory compliance requirements for biopharmaceuticals. Such a common sense business approach would need (1) to be applicable for all types of biopharmaceutical products both present and future, (2) to address the needs of a biopharmaceutical manufacturer from the beginning to the end of the clinical development stages and including post­ market approval, and (3) to be adaptable to the constantly changing CMC regulatory compliance requirements and guidance. Trying to accomplish this task was a humbling experience for this author! In Chapter 1, the CMC regulatory process is explained, the breadth of products included under the umbrella ofbiopharmaceuticals are identified, and the track record for the pharmaceutical and biopharmaceutical industry in meeting CMC regulatory compliance is discussed. In Chapter 2, while there are many CMC commonalities between biopharmaceuticals and chemically-synthesized pharmaceuticals, the significant differences in the way the regulatory agencies handle them are examined and the reasons for why such differences are necessary is discussed. Also, the importance of CMC FDA is stressed.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews